Emerging drugs for the treatment of acne. - Wikidata - awgldk - TriplyDB

Emerging drugs for the treatment of acne.

Emerging drugs for the treatment of acne.

http://www.wikidata.org/entity/Q34452033

about

Anti-Inflammatory Applications of Melittin, a Major Component of Bee Venom: Detailed Mechanism of Action and Adverse Effects The protective effect of bee venom on fibrosis causing inflammatory diseases Microbial biofilms and the human skin microbiome.

P2860

Q26749090-B10909CB-F0D7-4886-81DD-984945000802 Q38637342-F6B1BD93-21D0-4487-844B-AEADE3644841 Q39397814-9DBA57AB-2104-4973-B164-21EC5968B78C

P2860

Emerging drugs for the treatment of acne.

http://www.wikidata.org/entity/Q34452033

description

2014 nî lūn-bûn

@nan

2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Emerging drugs for the treatment of acne.

@ast

Emerging drugs for the treatment of acne.

@en

Emerging drugs for the treatment of acne.

@nl

type

label

Emerging drugs for the treatment of acne.

@ast

Emerging drugs for the treatment of acne.

@en

Emerging drugs for the treatment of acne.

@nl

prefLabel

Emerging drugs for the treatment of acne.

@ast

Emerging drugs for the treatment of acne.

@en

Emerging drugs for the treatment of acne.

@nl

P1433

Q34452033-7F299FA3-0471-4B99-A594-EF5967FBD716

P1476

Q34452033-CAECBA5B-787B-42DB-A8DD-546204054881

P2093

Q34452033-41F66D3D-0F38-411E-939D-0B84875DF1A1

Q34452033-BB21A7D1-109D-42FC-BB57-AE3F3E08E86A

P2860

Q34452033-06F123E3-8EA0-412F-872F-FB0A7A037F85

Q34452033-2F890899-5DF0-426A-872A-82AA7521B720

Q34452033-30D8B452-6D2E-4986-90D2-2FC24D7332C5

Q34452033-319FC5BF-6B1D-4AD1-A17F-C2A957366565

Q34452033-43DA572C-12B3-429B-9DA7-20C9E985B712

Q34452033-569308FB-EC7F-42D8-94D5-A3FA603D4D34

Q34452033-5F770E6A-940E-4714-A6F5-8DA998D8D0A5

Q34452033-6DCB1200-B48B-4F74-9C3F-07FE23D2F5F8

Q34452033-8C8E9E2E-23B8-4070-8F6E-6880353E7267

Q34452033-9714FBC3-4537-472C-9054-8AEA69E5AE29

P304

Q34452033-0E838C48-9ED0-4EEE-B6CC-91F503363382

P31

Q34452033-3309800F-10D1-4497-A996-1946079C61FD

P356

Q34452033-9343C46A-952D-479F-8DEE-F7E480A4CBA2

P407

Q34452033-00C266A8-4C92-4CF4-A903-C4ECBC1796CD

P433

Q34452033-D0645B16-10EC-4228-9C5D-5A9383C5A50B

P478

Q34452033-DB966C37-5E63-42B7-8624-BDAC8F0F2558

P50

Q34452033-2D14BAE9-66BF-42DF-AA48-5D046DFAD45E

P577

Q34452033-29142D73-3C75-455D-962C-F75F9F749566

P698

Q34452033-C5FF379B-E529-477B-AE71-808E273C8989

P356

14728214.2015.990373

P1433

Expert Opinion on Emerging Drugs

P1476

Emerging drugs for the treatment of acne.

@en

P2093

Alan Fleischer

http://www.w3.org/2001/XMLSchema#string

Imran Aslam

http://www.w3.org/2001/XMLSchema#string

P2860

Novel pharmacological approaches for the treatment of acne vulgaris

Topical aminolaevulinic acid-photodynamic therapy for the treatment of acne vulgaris: a study of clinical efficacy and mechanism of action.

The use of photodynamic therapy for treatment of acne vulgaris.

New insights into the management of acne: an update from the Global Alliance to Improve Outcomes in Acne group.

Selective photothermolysis to target sebaceous glands: theoretical estimation of parameters and preliminary results using a free electron laser.

Cortexolone 17α-propionate 1% cream, a new potent antiandrogen for topical treatment of acne vulgaris. A pilot randomized, double-blind comparative study vs. placebo and tretinoin 0·05% cream.

Management of acne: a report from a Global Alliance to Improve Outcomes in Acne.

Management of acne scarring, part II: a comparative review of non-laser-based, minimally invasive approaches.

Acne vulgaris: A review of causes and treatment options.

Effects of subantimicrobial-dose doxycycline in the treatment of moderate acne.

P304

91-101

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14728214.2015.990373

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

20

http://www.w3.org/2001/XMLSchema#string

P50

Steven R. Feldman

P577

2014-12-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25474485

http://www.w3.org/2001/XMLSchema#string